Co-Author
This page shows the publications co-authored by David Nathan and Stuart Orkin.
Connection Strength
5.615
-
Nathan DG, Orkin SH. Musings on genome medicine: Hepatitis C. Genome Med. 2010 Jan 27; 2(1):4.
Score: 0.467
-
Nathan DG, Orkin SH. Musings on genome medicine: enzyme-replacement therapy of the lysosomal storage diseases. Genome Med. 2009 Dec 09; 1(12):114.
Score: 0.463
-
Nathan DG, Orkin SH. Musings on genome medicine: Crohn's disease. Genome Med. 2009 Nov 05; 1(11):103.
Score: 0.460
-
Nathan DG, Orkin SH. Musings on genome medicine: the slow but inexorable process of medical care reform in the United States. Genome Med. 2009 Oct 12; 1(10):94.
Score: 0.458
-
Nathan DG, Orkin SH. Musings on genome medicine: the Obama effect redux. Genome Med. 2009 Sep 11; 1(9):86.
Score: 0.455
-
Nathan DG, Orkin SH. Musings on genome medicine: cholesterol and coronary artery disease. Genome Med. 2009 Jun 08; 1(6):60.
Score: 0.447
-
Nathan DG, Orkin SH. Musings on genome medicine: cancer genetics and the promise of effective treatment. Genome Med. 2009 May 06; 1(5):49.
Score: 0.444
-
Nathan DG, Orkin SH. Musings on genome medicine: gene therapy. Genome Med. 2009 Apr 03; 1(4):38.
Score: 0.442
-
Nathan DG, Orkin SH. Musings on genome medicine: the Obama effect. Genome Med. 2009 Mar 09; 1(3):30.
Score: 0.439
-
Nathan DG, Orkin SH. Musings on genome medicine: abuse of genetic tests. Genome Med. 2009 Feb 16; 1(2):18.
Score: 0.438
-
Nathan DG, Orkin SH. Musings on genome medicine: genome wide association studies. Genome Med. 2009 Jan 20; 1(1):3.
Score: 0.435
-
Orkin SH, Goff SC, Nathan DG. Heterogeneity of DNA deletion in gamma delta beta-thalassemia. J Clin Invest. 1981 Mar; 67(3):878-84.
Score: 0.063
-
Orkin SH, Nathan DG. The molecular genetics of thalassemia. Adv Hum Genet. 1981; 11:233-80.
Score: 0.062
-
Nathan DG, Alter BP, Orkin SH. Prenatal diagnosis of hemoglobinopathies. Clin Perinatol. 1979 Sep; 6(2):275-91.
Score: 0.057
-
Orkin SH, Old J, Lazarus H, Altay C, Gurgey A, Weatherall DJ, Nathan DG. The molecular basis of alpha-thalassemias: frequent occurrence of dysfunctional alpha loci among non-Asians with Hb H disease. Cell. 1979 May; 17(1):33-42.
Score: 0.055
-
Orkin SH, Old JM, Weatherall DJ, Nathan DG. Partial deletion of beta-globin gene DNA in certain patients with beta 0-thalassemia. Proc Natl Acad Sci U S A. 1979 May; 76(5):2400-4.
Score: 0.055
-
Orkin SH, Alter BP, Altay C, Mahoney MJ, Lazarus H, Hobbins JC, Nathan DG. Application of endonuclease mapping to the analysis and prenatal diagnosis of thalassemias caused by globin-gene deletion. N Engl J Med. 1978 Jul 27; 299(4):166-72.
Score: 0.053
-
Orkin SH, Nathan DG. The thalassemias. N Engl J Med. 1976 Sep 23; 295(13):710-4.
Score: 0.046
-
Orkin SH, Nathan DG. The molecular genetics of thalassemia. Birth Defects Orig Artic Ser. 1976; 12(8):145-59.
Score: 0.044
-
Sankaran VG, Ghazvinian R, Do R, Thiru P, Vergilio JA, Beggs AH, Sieff CA, Orkin SH, Nathan DG, Lander ES, Gazda HT. Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. J Clin Invest. 2012 Jul; 122(7):2439-43.
Score: 0.034
-
Miller BA, Salameh M, Ahmed M, Olivieri N, Huisman TH, Orkin SH, Nathan DG. Saudi Arabian sickle cell anemia. A molecular approach. Ann N Y Acad Sci. 1989; 565:143-51.
Score: 0.027
-
Miller BA, Salameh M, Ahmed M, Olivieri N, Antognetti G, Orkin SH, Huisman TH, Nathan DG. Analysis of hemoglobin F production in Saudi Arabian families with sickle cell anemia. Blood. 1987 Sep; 70(3):716-20.
Score: 0.025
-
Miller BA, Olivieri N, Salameh M, Ahmed M, Antognetti G, Huisman TH, Nathan DG, Orkin SH. Molecular analysis of the high-hemoglobin-F phenotype in Saudi Arabian sickle cell anemia. N Engl J Med. 1987 Jan 29; 316(5):244-50.
Score: 0.024
-
Miller BA, Salameh M, Ahmed M, Olivieri N, Huisman TH, Orkin SH, Nathan DG. Analysis of high fetal hemoglobin production in sickle cell anemia patients from the Eastern Province of Saudi Arabia. Prog Clin Biol Res. 1987; 251:415-26.
Score: 0.024
-
Miller BA, Salameh M, Ahmed M, Wainscoat J, Antognetti G, Orkin S, Weatherall D, Nathan DG. High fetal hemoglobin production in sickle cell anemia in the eastern province of Saudi Arabia is genetically determined. Blood. 1986 May; 67(5):1404-10.
Score: 0.023
-
Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B, Nathan DG. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest. 1984 Aug; 74(2):652-6.
Score: 0.020
-
Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B, Nathan DG. Hydroxyurea increases fetal hemoglobin production in sickle cell anemia. Trans Assoc Am Physicians. 1984; 97:268-74.
Score: 0.019
-
Alter BP, Orkin SH, Forget BG, Nathan DG. Prenatal diagnosis of hemoglobinopathies: the New England approach. Ann N Y Acad Sci. 1980; 344:151-64.
Score: 0.015
-
Ezekowitz RA, Sieff CA, Dinauer MC, Nathan DG, Orkin SH, Newburger PE. Restoration of phagocyte function by interferon-gamma in X-linked chronic granulomatous disease occurs at the level of a progenitor cell. Blood. 1990 Dec 15; 76(12):2443-8.
Score: 0.008
-
Wong C, Antonarakis SE, Goff SC, Orkin SH, Forget BG, Nathan DG, Giardina PJ, Kazazian HH. Beta-thalassemia due to two novel nucleotide substitutions in consensus acceptor splice sequences of the beta-globin gene. Blood. 1989 Mar; 73(4):914-8.
Score: 0.007
-
Antin JH, Ginsburg D, Smith BR, Nathan DG, Orkin SH, Rappeport JM. Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria: eradication of the PNH clone and documentation of complete lymphohematopoietic engraftment. Blood. 1985 Dec; 66(6):1247-50.
Score: 0.005
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.